•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quantum-Si Q3 Earnings Call Highlights
Quantum-Si incorporated (QSI) Q3 2026 Earnings Call Transcript
Quantum-Si Incorporated (QSI) Reports Q3 Loss, Misses Revenue Estimates
Quantum-Si Reports Third Quarter 2026 Financial Results and Provides Business Update
Head-To-Head Comparison: Quantum-Si (NASDAQ:QSI) vs. Quanterix (NASDAQ:QTRX)
Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026
Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement
Leading Indicators For The October Breakout Cycle
Beyond Elon Musk's Neuralink: Two Public Stocks With a Stake in the Brain Race
Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development Program
Head to Head Survey: Quantum-Si (NASDAQ:QSI) versus Twist Bioscience (NASDAQ:TWST)
Neuralink Stock: How to Invest Before the IPO
3 Biotech Stocks Put Traders Are Targeting Today
Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro
Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™
Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Quantum-Si incorporated (QSI) Q2 2026 Earnings Call Transcript
Quantum-Si Q2 Earnings Call Highlights